◆ 会议时间：2026年4月30日-5月2日
◆ 会议地点：瑞士 卢加诺（Lugano）

◆ 会议简介：

2026年晚期前列腺癌共识大会(APCCC)将于2026年4月30日-5月2日在瑞士卢加诺行，会议由晚期前列腺癌学会(APC)主办。APC学会是一个非营利性组织，其宗旨是改善晚期前列腺癌患者的治疗和护理。APCCC为从事晚期前列腺癌领域的医学专业人士和其他参与者来提供了一个独特的机会，他们可以参加最新的讲座，并与国际前列腺癌专家互动，了解他们日常实践的真实经验。APCCC旨在提供一个论坛，以讨论和辩论当前有关晚期前列腺癌患者临床管理的问题，会议有两天时间致力于高水准的陈述、讨论和辩论，以总结和概念化现有的文献和证据。会议最后由一个跨学科专家小组针对临床相关目标领域的预定义共识问题进行投票表决。会议结束后，一份带有这些专家建议的手稿将在同行评审的期刊上发表（2015年：Annals of Oncology；2017年：European Urology）。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

Advanced Prostate Cancer Consensus Conference (APCCC 2026)

Date: 30 April - 2 May , 2026
Venue: Lugano, Switzerland

Organized by: Advanced Prostate Cancer Society

Overview of APCCC

In advanced prostate cancer, rapid and successful drug development has resulted in multiple treatment options that require careful decision-making for individual patients. Clinicians face the increasingly difficult task of choosing from multiple potentially effective treatments that also are costly and potentially toxic. Further developments in novel next-generation imaging methods, biomarkers, molecular characterization, and genetic assays have led to many open questions and areas for which there is sparse or low-level evidence to support clinical decision-making.

The Advanced Prostate Cancer Consensus Conference (APCCC) was initiated to provide a forum to discuss and debate current questions on the clinical management of men with advanced prostate cancer, with a special focus on these unclear situations. Two days of the conference are dedicated to high-level presentations, discussions, and debates to summarize and conceptualize the available literature and evidence.

More than 100 of the world’s leading experts will form the consensus panel in 2024. They will also participate as moderators and or speakers in the conference programme. Following the conference, a manuscript with these expert recommendations is published in European Urology. See Publications here

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。